Maturation matters: Importance of maturation for antitumor immunity of dendritic cell vaccines

被引：13
作者：
Adams, S [1 ]
O'Neill, D [1 ]
Bhardwaj, N [1 ]
机构：
[1] NYU, Inst Canc, Sch Med, Tumor Vaccine Program, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 18期
关键词：
D O I：
10.1200/JCO.2004.99.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3834 / 3835
页数：2
相关论文
共 5 条
[1]   Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells [J].
Dhodapkar, MV ;
Steinman, RM ;
Krasovsky, J ;
Munz, C ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :233-238
[2]   A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection [J].
Jonuleit, H ;
Giesecke-Tuettenberg, A ;
Tüting, T ;
Thurner-Schuler, B ;
Stuge, TB ;
Paragnik, L ;
Kandemir, A ;
Lee, PP ;
Schuler, G ;
Knop, J ;
Enk, AH .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (02) :243-251
[3]   Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact [J].
McIlroy, D ;
Gregoire, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (10) :583-591
[4]   Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation [J].
Nair, S ;
McLaughlin, C ;
Weizer, A ;
Su, Z ;
Boczkowski, D ;
Dannull, J ;
Vieweg, J ;
Gilboa, E .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :6275-6282
[5]   Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells [J].
Slingluff, CL ;
Petroni, GR ;
Yamshchikov, GV ;
Barnd, DL ;
Eastham, S ;
Galavotti, H ;
Patterson, JW ;
Deacon, DH ;
Hibbitts, S ;
Teates, D ;
Neese, PY ;
Grosh, WW ;
Chianese-Bullock, KA ;
Woodson, EMH ;
Wiernasz, CJ ;
Merrill, P ;
Gibson, J ;
Ross, M ;
Engelhard, VH .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :4016-4026
1